Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 23;5(6):dlad125.
doi: 10.1093/jacamr/dlad125. eCollection 2023 Dec.

Does comorbidity index predict OPAT readmission?

Affiliations

Does comorbidity index predict OPAT readmission?

Ryan D Stubbs et al. JAC Antimicrob Resist. .

Abstract

Objectives: To determine if the Charlson comorbidity index (CCI) is an accurate predictor of unplanned readmissions for patients using outpatient parenteral antimicrobial therapy (OPAT) services.

Methods: Retrospective analysis of patients >16 years of age who had received OPAT at Lancashire Teaching Hospitals between 2019 and 2021. The number of unplanned hospitalizations was measured and categorized as OPAT related or non-OPAT related. The CCI for each patient group was calculated using an online tool, and logistic regression was used to assess the association between risk factors and risk of being readmitted.

Results: The cohort consisted of 741 patients. Unplanned readmission was seen in 112 patients (15.1%). The mean CCI score for patients with OPAT-related readmissions was 4.22, 0.92 higher than the mean for patients who were not readmitted (3.30). The mean CCI score for patients with non-OPAT-related readmissions was higher still at 4.89. The logistic regression showed that increased CCI, age, male gender and home location compared with clinic were associated with increased odds of readmission, although these effects did not meet statistical significance.

Conclusions: These results suggest that a higher CCI score is associated with a non-statistically significant increased risk of unplanned hospitalization. We concluded that the CCI may therefore be used in future decision-making regarding the acceptance of patients to OPAT and requires further investigation.

PubMed Disclaimer

References

    1. Chapman ALN, Patel S, Horner C et al. Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK. J Antimicrob Chemother 2019; 1: dlz026. 10.1093/jacamr/dlz026 - DOI - PMC - PubMed
    1. Yan M, Elligsen M, Simor AE et al. Patient characteristics and outcomes of outpatient parenteral antimicrobial therapy: a retrospective study. Can J Infect Dis Med Microbiol 2016; 2016: 8435257. 10.1155/2016/8435257 - DOI - PMC - PubMed
    1. Underwood J, Marks M, Collins S et al. Intravenous catheter-related adverse events exceed drug-related adverse events in outpatient parenteral antimicrobial therapy. J Antimicrob Chemother 2019; 74: 787–90. 10.1093/jac/dky474 - DOI - PMC - PubMed
    1. Keller SC, Wang N, Salinas A et al. Which patients discharged to home-based outpatient parenteral antimicrobial therapy are at high risk of adverse outcomes? Open Forum Infect Dis 2020; 7: ofaa178. 10.1093/ofid/ofaa178 - DOI - PMC - PubMed
    1. Gilchrist M, Barr D, Drummond F et al. Outpatient parenteral antimicrobial therapy (OPAT) in the UK: findings from the BSAC national outcomes registry (2015–19). J Antimicrob Chemother 2022; 77: 1481–90. 10.1093/jac/dkac047 - DOI - PubMed

LinkOut - more resources